Reproductive Medicine Center, Xiangya Hospital, Central South University, Changsha, China.
Yikon Genomics Company, Ltd., Suzhou, China.
Clin Transl Med. 2024 Mar;14(3):e1612. doi: 10.1002/ctm2.1612.
Structural rearrangements in highly repetitive heterochromatin regions can result in miscarriage or foetal malformations; however, detecting and preventing the transmission of these rearrangements has been challenging. Recently, the completion of sequencing of the complete human genome (T2T-CHM13) has made it possible to accurately characterise structural rearrangements in these regions. We developed a method based on T2T-CHM13 and nanopore sequencing to detect and block structural rearrangements in highly repetitive heterochromatin sequences.
T2T-CHM13-based "Mapping Allele with Resolved Carrier Status" was performed for couples who carry structural rearrangements in heterochromatin regions. Using nanopore sequencing and the T2T-CHM13 reference genome, the precise breakpoints of inversions and translocations close to the centromere were detected and haplotypes were constructed using flanking single-nucleotide polymorphisms (SNPs). Haplotype linkage analysis was then performed by comparing consistent parental SNPs with embryonic SNPs to determine whether the embryos carried hereditary inversions or balanced translocations. Based on copy number variation and haplotype linkage analysis, we transplanted normal embryos, which were further verified by an amniotic fluid test.
To validate this approach, we used nanopore sequencing of families with inversions and reciprocal translocations close to the centromere. Using the T2T-CHM13 reference genome, we accurately detected inversions and translocations in centromeres, constructed haplotypes and prevented the transmission of structural rearrangements in the offspring.
This study represents the first successful application of T2T-CHM13 in human reproduction and provides a feasible protocol for detecting and preventing the transmission of structural rearrangements of heterochromatin in embryos.
高度重复异染色质区域的结构重排可导致流产或胎儿畸形;然而,检测和防止这些重排的传播一直具有挑战性。最近,完成了完整人类基因组(T2T-CHM13)的测序,使得能够准确地描述这些区域的结构重排。我们开发了一种基于 T2T-CHM13 和纳米孔测序的方法,用于检测和阻断高度重复异染色质序列中的结构重排。
对携带异染色质区域结构重排的夫妇进行 T2T-CHM13 为基础的“带解析携带者状态的等位基因映射”。使用纳米孔测序和 T2T-CHM13 参考基因组,检测靠近着丝粒的倒位和易位的精确断点,并使用侧翼单核苷酸多态性(SNP)构建单倍型。然后通过比较一致的亲本 SNP 和胚胎 SNP 进行单倍型连锁分析,以确定胚胎是否携带遗传性倒位或平衡易位。基于拷贝数变异和单倍型连锁分析,我们移植了正常胚胎,进一步通过羊水检测进行验证。
为了验证这种方法,我们使用靠近着丝粒的倒位和相互易位的家庭进行纳米孔测序。使用 T2T-CHM13 参考基因组,我们准确地检测到了着丝粒的倒位和易位,构建了单倍型,并防止了结构重排在后代中的传播。
这项研究代表了 T2T-CHM13 在人类生殖中的首次成功应用,为检测和防止胚胎异染色质结构重排的传播提供了可行的方案。